Related Experiment Videos
Pathophysiology of nocturnal enuresis
1Institute of Experimental Clinical Research, University of Aarhus, Denmark.
Scandinavian Journal of Urology and Nephrology. Supplementum
|January 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?
European journal of pediatrics·2017
National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
The Journal of clinical endocrinology and metabolism·2014
Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
International journal of clinical practice·2009
Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
Neurourology and urodynamics·2005
Antidiuresis: a new concept in managing female daytime urinary incontinence.
BJU international·2004
The global burden of urinary bladder cancer.
Scandinavian journal of urology and nephrology. Supplementum·2008
Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
Scandinavian journal of urology and nephrology. Supplementum·2008
Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
Scandinavian journal of urology and nephrology. Supplementum·2008
Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.
Scandinavian journal of urology and nephrology. Supplementum·2008
How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
Scandinavian journal of urology and nephrology. Supplementum·2008
Gene signatures for risk-adapted treatment of bladder cancer.
Scandinavian journal of urology and nephrology. Supplementum·2008
Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β.
Journal of Zhejiang University. Science. B·2026
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran.
Neurodegenerative disease management·2026
Three Cases of Primary Central Airway Tumors of Neurological and Neuroendocrine Origin in Children.
Journal of pediatrics. Clinical practice·2026